Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
IQVIA Holdings Inc (IQV)
NYSE:IQV
Holding IQV?
Track your performance easily
See the Price Targets and Ratings of:
IQV Analyst Ratings
Strong Buy
16 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IQV Stock 12 Month Forecast
Average Price Target
$254.56
▲(26.13% Upside)
| Highest Price Target$276.00 | Average Price Target$254.56 | Lowest Price Target$195.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Deutsche Bank
Reiterated
11/21/24
Mizuho Securities
Reiterated
11/18/24
Argus Research
Reiterated
11/06/24
RBC Capital
Reiterated
11/05/24
Stifel Nicolaus
Reiterated
11/04/24
J.P. Morgan
Reiterated
11/04/24
Morgan Stanley
Reiterated
11/04/24
BTIG
Reiterated
11/04/24
Truist Financial
Reiterated
11/04/24
Goldman Sachs
Reiterated
11/01/24
TD Cowen
$255
Buy
26.35%
Upside
Assigned
11/01/24
IQVIA Holdings: Buy Rating Driven by Strategic Partnerships and Growth Prospects
Bank of America Securities
$255
Buy
26.35%
Upside
Reiterated
11/01/24
Resilient Performance and Strategic Growth Drive IQVIA Holdings Buy Rating
Barclays
$260→$255
Buy
26.35%
Upside
Reiterated
11/01/24
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Alphatec Holdings (NASDAQ: ATEC) and Alnylam Pharma (NASDAQ: ALNY)
Evercore ISI
$235
Buy
16.44%
Upside
Assigned
11/01/24
IQVIA Holdings (IQV) PT Lowered to $235 at Evercore ISIEvercore ISI analyst Elizabeth Anderson lowered the price target on IQVIA Holdings (NYSE: IQV) to $235.00 (from $265.00) while maintaining a Outperform rating.
Jefferies
$195
Hold
-3.38%
Downside
Reiterated
10/31/24
We thought not quite half, but IQV's comments sounded reflected more progress (maybe 6th, instead of 4th inning). Competitively, IQV has done well, renewing all large pharma partnerships and expanding scope in ~6. Mgt says that the large cancellation and mega trial delays are unrelated to broader restructurings or ICLR's customers who halted work. But the broader point is that delays and cancels for "normal" reasons are much harder to absorb when exacerbated by budget and strategic overhauls that are broad-based currently.
Best Analysts Covering IQVIA Holdings
Which Analyst Should I Follow If I Want to Buy IQV and Sell After:
1 Month
xxx
Success Rate
9/12 ratings generated profit
Average Return
+1.88%
assigned a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +1.88% per trade.
3 Months
xxx
Success Rate
21/33 ratings generated profit
Average Return
+2.61%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +2.61% per trade.
1 Year
2 Years
xxx
Success Rate
7/11 ratings generated profit
Average Return
+14.44%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 63.64% of your transactions generating a profit, with an average return of +14.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IQV Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
26
17
17
16
30
Hold
5
4
4
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
21
21
19
33
Each month's total comprises the sum of three months' worth of ratings.
IQV Financial Forecast
IQV Stock Forecast FAQ
What is IQV’s average 12-month price target, according to analysts?
Based on analyst ratings, IQVIA Holdings Inc’s 12-month average price target is $254.56.
What is IQV’s upside potential, based on the analysts’ average price target?
IQVIA Holdings Inc has 26.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is IQV a Buy, Sell or Hold?
IQVIA Holdings Inc has a consensus rating of Strong Buy which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
What is IQVIA Holdings Inc’s price target?
The average price target for IQVIA Holdings Inc is $254.56. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $276.00 ,the lowest forecast is $195.00. The average price target represents 26.13% Increase from the current price of $201.82.
The highest analyst price target is $276.00 ,the lowest forecast is $195.00. The average price target represents 26.13% Increase from the current price of $201.82.
What do analysts say about IQVIA Holdings Inc?
IQVIA Holdings Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of IQV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.